Top Stories
A smart phone on a desk with Anthropic's Claude logo on the screen

Anthropic confidentially files for IPO: Here's what it means

Anthropic announced today that it had " confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of our common stock." An S-1 is the registration document a company files with regulators before it

A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

Latest News

Arrow Announces IC-3, IC-4HZ, and IC-5HZ Well Results

Newsfile

Icaco 3, Icaco 4 horizontal & Icaco 5 horizontal successfully drilled and on productionCalgary, Alberta--(Newsfile Corp. - August 7, 2026) - Arrow Exploration Corp. (AIM: AXL) (TSXV: AXL) ("Arrow" or the "Company"), the high-growth operator with a po

ArchieVerse Announces Major Platform Update

Newsfile

Miami, Florida--(Newsfile Corp. - August 7, 2026) - ArchieVerse, the AI-powered real estate platform known as "The Everything App," today announced a major update to its AI model and platform, introducing direct in-app voice and video calling and exp

Pinnacle Acquisition Corporation Announces Pricing of $200 Million Initial Public Offering

GlobeNewswire Inc.

Palm Beach, FL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pinnacle Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Excha

AD

BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering

GlobeNewswire Inc.

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., (“BlossomHill Therapeutics”), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small molecule medicines for

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering

GlobeNewswire Inc.

THOUSAND OAKS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Latigo Biotherapeutics, Inc. (“Latigo”), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines, today announced the pricing of its upsized init

Adaptogenics Health Corp. Announces Change of Directors

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") is pleased to announce the appointment of Mr. Gurinder Sandhu as a director of the Company effective immediately.Mr

Wesdome Files Updated Technical Reports for Eagle River and Kiena Mines; Establishes Long Life Reserve Plans with Substantial Upside Potential

Newsfile

Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - Wesdome Gold Mines Ltd. (TSX: WDO) (OTCQX: WDOFF) ("Wesdome" or the "Company") today announced that it has filed independent technical reports (the "Technical Reports") prepared in accordance with

TEAM, INC. Schedules Second Quarter 2026 Earnings Release and Conference Call

GlobeNewswire Inc.

SUGAR LAND, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietar

Santacruz Silver Announces Equity Incentive Grants

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Santacruz Silver Mining Ltd. (NASDAQ: SCZM) (TSXV: SCZ) ("Santacruz" or the "Company") announces that the Company has granted an aggregate of 304,000 performance share units ("PSUs"), 2

Tango Therapeutics Announces Executive Chair Transition

GlobeNewswire Inc.

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Webe

AD